Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

biomarker

  • You have access
    Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma
    TAKASHI KATO, TARO OSHIKIRI, HIRONOBU GOTO, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI
    Anticancer Research May 2022, 42 (5) 2775-2782; DOI: https://doi.org/10.21873/anticanres.15757
  • Open Access
    sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma
    VIVIAN BARAK, INA KALICKMAN and JACOB PE’ER
    Anticancer Research March 2022, 42 (3) 1447-1453; DOI: https://doi.org/10.21873/anticanres.15615
  • You have access
    The Gut Microbiome as a Biomarker of Cancer Progression Among Female Never-smokers With Lung Adenocarcinoma
    TAKEHIRO OTOSHI, TATSUYA NAGANO, JONGUK PARK, KOJI HOSOMI, TOMOYA YAMASHITA, MOTOKO TACHIHARA, TOKIKO TABATA, REINA SEKIYA, YUGO TANAKA, KAZUYUKI KOBAYASHI, KENJI MIZUGUCHI, TOMOO ITOH, YOSHIMASA MANIWA, JUN KUNISAWA and YOSHIHIRO NISHIMURA
    Anticancer Research March 2022, 42 (3) 1589-1598; DOI: https://doi.org/10.21873/anticanres.15633
  • You have access
    CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
    TOSHIAKI HAGIWARA, KIICHI SUGIMOTO, HIROTAKA MOMOSE, TAKAHIRO IRIE, KUMPEI HONJO, YU OKAZAWA, MASAYA KAWAI, SHINGO KAWANO, SHINYA MUNAKATA, MAKOTO TAKAHASHI, YUTAKA KOJIMA, NOBUKO SERIZAWA, AKIHITO NAGAHARA, ROBERT M. HOFFMAN, MALCOLM V. BROCK and KAZUHIRO SAKAMOTO
    Anticancer Research February 2022, 42 (2) 697-707; DOI: https://doi.org/10.21873/anticanres.15528
  • You have access
    Clinical Impact of CYFRA 21-1 a Marker for Treatment Failure in Patients With Oropharyngeal Cancer Treated by Radio(chemo)therapy
    STEFAN A. RUDHART, PHILIPP LANGEN, KRUTHIKA THANGAVELU, FRANCESCA GEHRT, PETAR STANKOVIC, THOMAS WILHELM, BORIS A. STUCK and STEPHAN HOCH
    Anticancer Research January 2022, 42 (1) 137-146; DOI: https://doi.org/10.21873/anticanres.15467
  • You have access
    MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer
    BETTINA SAVARESE-BRENNER, MARLENE HEUGL, BARBARA RATH, CONRADIN SCHWEIZER, EVA OBERMAYR, SANDRA STICKLER and GERHARD HAMILTON
    Anticancer Research January 2022, 42 (1) 429-439; DOI: https://doi.org/10.21873/anticanres.15501
  • You have access
    Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8+ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)
    SATORU YONEKURA
    Anticancer Research January 2022, 42 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.15509
  • You have access
    DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer
    JIANCHUN WU, KATE JILLIAN GALVAN, RYAN D. BOGARD, CARYN E. PETERSON, ARDAMAN SHERGILL and DAVID L. CROWE
    Anticancer Research November 2021, 41 (11) 5393-5403; DOI: https://doi.org/10.21873/anticanres.15351
  • You have access
    Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    YUJI NOJIMA, KATSUHIKO SHIMIZU, SHINSUKE SAISHO, AI MAEDA, TAKESHI KUROSAKI, KOJI KUROSE, TORU OGA, MIKIO OKA and MASAO NAKATA
    Anticancer Research November 2021, 41 (11) 5469-5475; DOI: https://doi.org/10.21873/anticanres.15359
  • You have access
    Analysis of Mesencephalic Astrocyte-derived Neurotrophic Factor in Multiple Myeloma
    AMANDINE DERNONCOURT, CHLOE SAUZAY, JEAN SCHMIDT, CHRISTOPHE LOUANDRE, CATHY GOMILA, PIERRE DUHAUT, YVES-EDOUARD HERPE, ZUZANA SAIDAK, ANTOINE GALMICHE and VALERY SALLE
    Anticancer Research September 2021, 41 (9) 4305-4312; DOI: https://doi.org/10.21873/anticanres.15235

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 12
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire